113TH CONGRESS
   1ST SESSION       H. R. 225
                     AN ACT
To amend title IV of the Public Health Service Act to
   provide for a National Pediatric Research Network, in-
   cluding with respect to pediatric rare diseases or condi-
   tions.
 1      Be it enacted by the Senate and House of Representa-
 2 tives of the United States of America in Congress assembled,
 1   SECTION 1. SHORT TITLE.    2
 2       This Act may be cited as the ‘‘National Pediatric Re-
 3 search Network Act of 2013’’.
 4   SEC. 2. NATIONAL PEDIATRIC RESEARCH NETWORK.
 5       Section 409D of the Public Health Service Act (42
 6 U.S.C. 284h; relating to the Pediatric Research Initiative)
 7 is amended—
 8            (1) by redesignating subsection (d) as sub-
 9       section (f); and
10            (2) by inserting after subsection (c) the fol-
11       lowing:
12       ‘‘(d) NATIONAL PEDIATRIC RESEARCH NETWORK.—
13            ‘‘(1) NETWORK.—In carrying out the Initiative,
14       the Director of NIH, acting through the Director of
15       the Eunice Kennedy Shriver National Institute of
16       Child Health and Human Development and in col-
17       laboration with other appropriate national research
18       institutes and national centers that carry out activi-
19       ties involving pediatric research, may provide for the
20       establishment of a National Pediatric Research Net-
21       work consisting of the pediatric research consortia
22       receiving awards under paragraph (2).
23            ‘‘(2) PEDIATRIC   RESEARCH CONSORTIA.—

24                 ‘‘(A) IN   GENERAL.—The    Director of the
25            Institute may award funding, including through


      •HR 225 EH               3
 1           grants, contracts, or other mechanisms, to pub-
 2           lic or private nonprofit entities—
 3                      ‘‘(i) for planning, establishing, or
 4                strengthening pediatric research consortia;
 5                and
 6                      ‘‘(ii) for providing basic operating
 7                support for such consortia, including with
 8                respect to—
 9                          ‘‘(I) basic, clinical, behavioral, or
10                      translational research to meet unmet
11                      needs for pediatric research; and
12                          ‘‘(II) training researchers in pe-
13                      diatric research techniques in order to
14                      address      unmet   pediatric   research
15                      needs.
16                ‘‘(B) RESEARCH.—The Director of NIH
17           shall ensure that—
18                      ‘‘(i) each consortium receiving an
19                award under subparagraph (A) conducts or
20                supports at least one category of research
21                described in subparagraph (A)(ii)(I) and
22                collectively such consortia conduct or sup-
23                port all such categories of research; and




     •HR 225 EH                4
1                         ‘‘(ii) one or more such consortia pro-
2                 vide training described in subparagraph
3                 (A)(ii)(II).
4                 ‘‘(C) NUMBER       OF CONSORTIA.—The     Direc-
5            tor of NIH may make awards under this para-
6            graph for not more than 20 pediatric research
7            consortia.
 8                ‘‘(D) ORGANIZATION         OF CONSORTIUM.—
 9           Each consortium receiving an award under sub-
10           paragraph (A) shall—
11                        ‘‘(i) be formed from a collaboration of
12                cooperating institutions;
13                        ‘‘(ii) be coordinated by a lead institu-
14                tion;
15                        ‘‘(iii) agree to disseminate scientific
16                findings, including from clinical trials, rap-
17                idly and efficiently; and
18                        ‘‘(iv) meet such requirements as may
19                be prescribed by the Director of NIH.
20                ‘‘(E) SUPPLEMENT,       NOT SUPPLANT.—Any
21           support received by a consortium under sub-
22           paragraph (A) shall be used to supplement, and
23           not supplant, other public or private support for
24           activities authorized to be supported under this
25           paragraph.


     •HR 225 EH             5
1                 ‘‘(F) DURATION   OF SUPPORT.—Support       of
2            a consortium under subparagraph (A) may be
3            for a period of not to exceed 5 years. Such pe-
4            riod may be extended at the discretion of the
5            Director of NIH.
 6           ‘‘(3) COORDINATION        OF   CONSORTIA   ACTIVI-
 7      TIES.—The   Director of NIH shall—
 8                ‘‘(A) as appropriate, provide for the coordi-
 9           nation of activities (including the exchange of
10           information and regular communication) among
11           the consortia established pursuant to paragraph
12           (2); and
13                ‘‘(B) require the periodic preparation and
14           submission to the Director of reports on the ac-
15           tivities of each such consortium.
16           ‘‘(4) ASSISTANCE     WITH      REGISTRIES.—Each
17      consortium receiving an award under paragraph
18      (2)(A) shall provide assistance to the Centers for
19      Disease Control and Prevention in the establishment
20      or expansion of patient registries and other surveil-
21      lance systems as appropriate and upon request by
22      the Director of the Centers.
23      ‘‘(e) RESEARCH   ON   PEDIATRIC RARE DISEASES       OR
24 CONDITIONS.—
     •HR 225 EH                6
 1           ‘‘(1) IN     GENERAL.—In     making awards under
 2      subsection (d)(2) for pediatric research consortia,
 3      the Director of NIH shall ensure that an appro-
 4      priate number of such awards are awarded to such
 5      consortia that agree to—
 6                ‘‘(A) focus primarily on pediatric rare dis-
 7           eases or conditions (including any such diseases
 8           or conditions that are genetic disorders (such as
 9           spinal muscular atrophy and Duchenne mus-
10           cular dystrophy) or are related to birth defects
11           (such as Down syndrome and fragile X)); and
12                ‘‘(B) conduct or coordinate one or more
13           multisite clinical trials of therapies for, or ap-
14           proaches to, the prevention, diagnosis, or treat-
15           ment of one or more pediatric rare diseases or
16           conditions.
17           ‘‘(2) DATA    COORDINATING CENTER.—

18                ‘‘(A)     ESTABLISHMENT.—In          connection
19           with support of consortia described in para-
20           graph (1), the Director of NIH shall establish
21           a data coordinating center for the following
22           purposes:
23                        ‘‘(i) To distribute the scientific find-
24                ings referred to in paragraph (1)(C).




     •HR 225 EH                7
 1                     ‘‘(ii) To provide assistance in the de-
 2                sign and conduct of collaborative research
 3                projects and the management, analysis,
 4                and storage of data associated with such
 5                projects.
 6                     ‘‘(iii)   To   organize   and   conduct
 7                multisite monitoring activities.
 8                ‘‘(B) REPORTING.—The Director of NIH
 9           shall—
10                     ‘‘(i) require the data coordinating cen-
11                ter established under subparagraph (A) to
12                provide regular reports to the Director of
13                NIH and the Commissioner of Food and
14                Drugs on research conducted by consortia
15                described in paragraph (1), including infor-
16                mation on enrollment in clinical trials and
17                the allocation of resources with respect to
18                such research; and
19                     ‘‘(ii) as appropriate, incorporate infor-
20                mation reported under clause (i) into the




     •HR 225 EH            8
1                 Director’s biennial reports under section
2                 403.’’.
        Passed the House of Representatives February 4,
    2013.
        Attest:




                                                   Clerk.




     •HR 225 EH
113TH CONGRESS
   1ST SESSION      H. R. 225
                 AN ACT
To amend title IV of the Public Health Service Act
  to provide for a National Pediatric Research Net-
  work, including with respect to pediatric rare dis-
  eases or conditions.
